rs1050565
| Orientation | minus |
| Stabilized | minus |
| Geno | Mag | Summary |
|---|---|---|
| (A;A) | 0 | normal |
| (A;G) | 0 | normal |
| (G;G) | 2 | if testicular cancer patient, 5x poorer response to bleomycin chemotherapy |
| Reference | GRCh38 38.1/141 |
| Chromosome | 17 |
| Position | 30249058 |
| Gene | BLMH |
| is a | snp |
| is | mentioned by |
| dbSNP | rs1050565 |
| dbSNP (classic) | rs1050565 |
| ClinGen | rs1050565 |
| ebi | rs1050565 |
| HLI | rs1050565 |
| Exac | rs1050565 |
| Gnomad | rs1050565 |
| Varsome | rs1050565 |
| LitVar | rs1050565 |
| Map | rs1050565 |
| PheGenI | rs1050565 |
| Biobank | rs1050565 |
| 1000 genomes | rs1050565 |
| hgdp | rs1050565 |
| ensembl | rs1050565 |
| geneview | rs1050565 |
| scholar | rs1050565 |
| rs1050565 | |
| pharmgkb | rs1050565 |
| gwascentral | rs1050565 |
| openSNP | rs1050565 |
| 23andMe | rs1050565 |
| SNPshot | rs1050565 |
| SNPdbe | rs1050565 |
| MSV3d | rs1050565 |
| GWAS Ctlg | rs1050565 |
| GMAF | 0.2736 |
| Max Magnitude | 2 |
| ? | (A;A) (A;G) (G;G) | 28 |
|---|---|---|
|
| ||
Testicular cancer patients may be treated with bleomycin, a cytotoxic drug that is essential component of chemotherapy regimens for this cancer, officially known as disseminated testicular germ-cell cancer (TC). rs1050565 is a SNP in the BLMH gene. This gene encodes a protein that can inactivate bleomycin.
Based on a study of 300 TC patients treated with bleomycin, a testicular cancer patient with a rs1050565(G;G) genotype has an odds ratio of 4.97 (CI: 2.17 - 11.39) for TC-related death compared to (A;G) or (A;A) genotypes. The rs1050565(G;G) genotype also shows a higher prevalence of early relapses.[PMID 18398146]
| ClinVar | |
|---|---|
| Risk | Rs1050565(G;G) |
| Alt | Rs1050565(G;G) |
| Reference | Rs1050565(A;A) |
| Significance | Non-pathogenic |
| Disease | BLEOMYCIN HYDROLASE POLYMORPHISM |
| Variation | info |
| Gene | BLMH |
| CLNDBN | BLEOMYCIN HYDROLASE POLYMORPHISM |
| Reversed | 1 |
| HGVS | NC_000017.10:g.28576076T>C |
| CLNSRC | OMIM Allelic Variant UniProtKB (protein) |
| CLNACC | RCV000007670.2, |
[PMID 15995945
] Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors.
[PMID 19673036
] Association of tagging single nucleotide polymorphisms on 8 candidate genes in dopaminergic pathway with schizophrenia in Croatian population.
- Is a snp
- In dbSNP
- SNPs on chromosome 17
- Has genotype
- Has population
- Uses omim
- On chip 23andMe v1
- On chip 23andMe v2
- On chip 23andMe v3
- On chip 23andMe v4
- On chip Affy GenomeWide 6
- On chip Ancestry v2
- On chip FTDNA2
- On chip FTDNA
- On chip HumanOmni1Quad
- On chip Illumina Human 1M
- On chip 23andMe v5
- On chip Ancestry v2c
- On chip Ancestry v2d
